This latest recall is due to a heightened risk that the devices will stop working with no warning. There have been 42 customer complaints reported so far. 

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them. 

Medtronic launched its MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with compatible cardiac devices.

Overall, cardiologists made corrections to 16.8% of AI-generated assessments and 27.2% of sonographer assessments.

According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.

Low-fat diets were also linked to certain benefits, including a reduced heart attack risk. 

The devices have been hit with multiple recalls in recent months. Those issues are now impacting sales outside of the United States as well.

According to a new study of more than 119,000 hospitalizations, the costs associated with TAVR are far from consistent. 

Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies.